ALMKT:EPA
Mauna Kea Technologies SA
€0.091
arrow_downward
-1.08%(-0.00100) 1 日
11月16日, 16:39:49 GMT+1 · EUR
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoALMKT の上位の分析情報を生成しています...
始値
€0.09
高値
€0.09
安値
€0.09
時価総額
1828.28万
平均出来高
48.45万
取引量
36.13万
株価収益率
0.78
52 週高値
€0.23
52 週安値
€0.07
EPS
€0.12
発行済株式数
1.95億
従業員数
56
始値
€0.09
高値
€0.09
安値
€0.09
時価総額
1828.28万
平均出来高
48.45万
取引量
36.13万
株価収益率
0.78
52 週高値
€0.23
52 週安値
€0.07
EPS
€0.12
発行済株式数
1.95億
従業員数
56
ニュース記事
情報源: ウェブソース、ニュース パートナー
Benzinga
·
20 分前
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
RealMoney Pro
·
48 分前
Charting the S&P 500: Hanging by a Thread to Bullish Signals
MarketWatch
·
34 分前
These 13 S&P 500 stocks can rise up to 70% over the next year, according to analysts
Traders Union
·
45 分前
Peter Tuchman: S&P 500 loses over $800 billion in market cap
プロフィール
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA について